In Vitro Synergy and In Vivo Activity of Tigecycline-Ciprofloxacin Combination Therapy against Vibrio vulnificus Sepsis

The mortality rate associated with Vibrio vulnificus sepsis remains high. An in vitro time-kill assay revealed synergism between tigecycline and ciprofloxacin. The survival rate was significantly higher in mice treated with tigecycline plus ciprofloxacin than in mice treated with cefotaxime plus min...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Antimicrob Agents Chemother
Auteurs principaux: Kim, Seong Eun, Kim, Hee Kyung, Choi, Su-Mi, Yu, Yohan, Kim, Uh Jin, Darboe, Kalifa Sanneh, Kang, Seung-Ji, Park, Kyung-Hwa, Kang, Gaeun, Kim, Young Ran, Rhee, Joon Haeng, Jung, Sook-In, Jang, Hee-Chang
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2019
Sujets:
Experimental Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6761547/
https://ncbi.nlm.nih.gov/pubmed/31332060
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00310-19
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires